scholarly journals Troponin T Elevation After Percutaneous Left Atrial Appendage Occlusion

2021 ◽  
Vol 8 ◽  
Author(s):  
Xiaoyan Wang ◽  
Xueying Chen ◽  
Yong Ye ◽  
Juan Peng ◽  
Jinyi Lin ◽  
...  

Background: Cardiac troponin T (cTNT) has been widely used in detecting cardiac damage. Elevated cTNT level has been reported to be associated with increased mortality in multiple cardiac conditions. It is not uncommon to observe an increased level of cTNT in patients after left atrial appendage occlusion (LAAO). The objective of the study is to study the incidence, significance, and factors associated with cTNT elevation after LAAO.Methods: We prospectively included patients who underwent LAAO from January 2019 to July 2020 in Fudan Zhongshan Hospital. Patients were divided into those with elevated cTNT after procedure and those with normal postprocedure cTNT. All individuals were followed up for 1 year. The primary outcome is major adverse cardiovascular events, which include myocardial infarction, heart failure, cardiac death, and stroke. The second outcome is periprocedure complication, including chest pain, tachycardia, cardiac tamponade, change of electrocardiograph, and atrial thrombus.Results: A total of 190 patients were enrolled. Of the patients, 85.3% had elevated cTNT after LAAO, while 14.7% of them did not. Exposure time, dosage of contrast, types of devices, shapes, and sizes of LAA could contribute to elevated postprocedure cTNT. We found that patients with a Watchman device were more likely to have elevated postprocedure cTNT than those with a Lambre device (89.2 vs. 76.7%, p = 0.029). LAAO shapes were associated with cTNT levels in patients with a Watchman device, while the diameter of the outer disc and LAA depth mattered for the Lambre device. There was no significant difference in the primary and second outcome between the two groups (p-value: 0.619, 0.674).Conclusion: LAAO was found to be commonly accompanied with cTNT elevation, which might not to be related to the complications and adverse cardiac outcomes within 1 year of follow-up. Moreover, eGFR at baseline, exposure time, dosage of contrast, types of LAAO device, and LAA morphology could contribute to cTNT elevation.

2013 ◽  
Vol 62 (18) ◽  
pp. C29 ◽  
Author(s):  
Ömer Sanatci ◽  
Anja Schade ◽  
Guido Groschup ◽  
K. Wehner ◽  
Burghard Schumacher ◽  
...  

2020 ◽  
Vol 75 (11) ◽  
pp. 1216
Author(s):  
Nidhi Madan ◽  
Mark Kosinski ◽  
Konstantinos Voudris ◽  
Nusrat Jahan ◽  
Luke R. McCormack ◽  
...  

2019 ◽  
Vol 12 (11) ◽  
pp. e93-e94 ◽  
Author(s):  
Henry D. Huang ◽  
Joshua J. Murphy ◽  
Abhishek Sharma ◽  
Clifford J. Kavinsky ◽  
Marie-France Poulin

2017 ◽  
Vol 36 (7-8) ◽  
pp. 525-532 ◽  
Author(s):  
Ana Rita G. Francisco ◽  
Eduardo Infante de Oliveira ◽  
Miguel Nobre Menezes ◽  
Pedro Carrilho Ferreira ◽  
Pedro Canas da Silva ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document